Matches in Wikidata for { <http://www.wikidata.org/entity/Q62031237> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q62031237 description "assaig clínic" @default.
- Q62031237 description "clinical trial" @default.
- Q62031237 description "clinical trial" @default.
- Q62031237 description "clinical trial" @default.
- Q62031237 description "clinical trial" @default.
- Q62031237 description "ensaio clínico" @default.
- Q62031237 description "ensayo clínico" @default.
- Q62031237 description "ensayu clínicu" @default.
- Q62031237 description "essai clinique" @default.
- Q62031237 description "klinisch onderzoek" @default.
- Q62031237 description "клінічне випробування" @default.
- Q62031237 description "կլինիկական փորձարկում" @default.
- Q62031237 description "临床试验" @default.
- Q62031237 name "To Optimize the Therapeutic Pathway of Peginterferon Treatment in Patients With CHB Based on IFNA2p.Ala120Thr /ISGs." @default.
- Q62031237 type Item @default.
- Q62031237 label "To Optimize the Therapeutic Pathway of Peginterferon Treatment in Patients With CHB Based on IFNA2p.Ala120Thr /ISGs." @default.
- Q62031237 prefLabel "To Optimize the Therapeutic Pathway of Peginterferon Treatment in Patients With CHB Based on IFNA2p.Ala120Thr /ISGs." @default.
- Q62031237 P1050 Q62031237-0B67E466-E5E5-45D8-9363-F53674C407EF @default.
- Q62031237 P1050 Q62031237-35EFF4EE-E072-4B7C-AE1D-A497286C8382 @default.
- Q62031237 P1050 Q62031237-3A7915BE-BFAB-4962-BDFE-4DC36AEAAA86 @default.
- Q62031237 P1132 Q62031237-4FF68609-8724-4F10-B306-725EC57ECE67 @default.
- Q62031237 P1476 Q62031237-E24EC10C-B0BD-4EC1-AE2C-1B6FAFB84EDC @default.
- Q62031237 P1813 Q62031237-76370210-62D3-4823-864E-ADB2E4A68CD8 @default.
- Q62031237 P2899 Q62031237-C98CD8DF-0AE3-42ED-9060-B6EBC70FE834 @default.
- Q62031237 P3098 Q62031237-BB881011-3482-4665-9514-B1AC4AE85E59 @default.
- Q62031237 P31 Q62031237-C3A86D36-318B-43EA-8985-5D0029AFE3DE @default.
- Q62031237 P4135 Q62031237-2CA89951-93E4-4506-99C4-516E7FF0DA4E @default.
- Q62031237 P4844 Q62031237-5E11ACCD-F1C3-434F-BF24-AD6AFFF4B64D @default.
- Q62031237 P4844 Q62031237-6935AB61-C45F-46E5-9777-6CFEE3A23002 @default.
- Q62031237 P580 Q62031237-AE0DA803-6115-4631-87DA-F3F50743A720 @default.
- Q62031237 P582 Q62031237-C2F45172-792D-4449-AA95-949486A66C6A @default.
- Q62031237 P8005 Q62031237-3DFE1C1C-C20F-4180-9723-105A923091C5 @default.
- Q62031237 P8363 Q62031237-CF5BDFD5-D388-4950-B3B8-148A984F359E @default.
- Q62031237 P859 Q62031237-0DFB0A1F-2BF6-460F-9562-6B7224FA95E2 @default.
- Q62031237 P1050 Q131742 @default.
- Q62031237 P1050 Q157661 @default.
- Q62031237 P1050 Q6853 @default.
- Q62031237 P1132 "+160" @default.
- Q62031237 P1476 "A Multicenter Clinical Study to Optimize the Therapeutic Pathway of Peginterferon Alfa-2b Treatment in Patients With Chronic Hepatitis B Based on IFNA2p.Ala120Thr /ISGs Gene Spectrum." @default.
- Q62031237 P1813 "IFNA2/ISGs" @default.
- Q62031237 P2899 "+18" @default.
- Q62031237 P3098 "NCT03771677" @default.
- Q62031237 P31 Q30612 @default.
- Q62031237 P4135 "+65" @default.
- Q62031237 P4844 Q20817235 @default.
- Q62031237 P4844 Q7160789 @default.
- Q62031237 P580 "2019-01-01T00:00:00Z" @default.
- Q62031237 P582 "2023-12-30T00:00:00Z" @default.
- Q62031237 P8005 Q76649614 @default.
- Q62031237 P8363 Q78089383 @default.
- Q62031237 P859 Q178972 @default.